Solutions / Urgent Care
Differentiate dysuria, discharge, and pelvic pain — before the patient leaves.
Six-analyte urine panel for the walk-in workup. UroSure separates STI, BV, and yeast at point of care, so your clinicians aren't guessing while waiting on a send-out lab.
The problem
Walk-in urogenital complaints are a differential, not a diagnosis.
Dysuria, discharge, and pelvic pain are some of the most common urgent-care presentations. Standard urinalysis can't tell STI from UTI from BV from yeast, and the patient won't be back tomorrow when the send-out result lands.
- 01 Standard urinalysis flags WBC and nitrites but doesn't differentiate STI from UTI from BV from yeast — leaving clinicians to weigh empiric pathways with incomplete data.
- 02 Send-out NAAT confirms the picture two-to-seven days later, after the prescribing decision has already been made.
- 03 Patients with ambiguous results return for second visits or are lost to follow-up entirely — both bad for outcomes and operations.
- 04 Without analyte-level detail, clinics carry liability for empiric overuse of broad-spectrum agents.
UroSure fit
Read six analytes before the visit ends.
UroSure produces an analyte-level readout from a single urine specimen in about fifteen minutes. The clinician keeps the decision; UroSure gives them the data to make it during the visit instead of after.
01
Fit
- Same-visit differentiation of CT, NG, TV, MG, Candida, and Gardnerella from one urine cup.
- Built-in control band on every cassette confirms the run is valid before result is read out.
- Single specimen means no swab handoffs, no chain-of-custody complications mid-shift.
- Documentation and CPT coding happen during the encounter — no callback queue.
02
Use cases
- Symptomatic walk-in: dysuria, discharge, pelvic pain, or post-exposure concern.
- Differential support when standard UA is positive but the analyte is unclear.
- Telehealth-affiliated brick-and-mortar where same-visit result closes the encounter.
03
Economics
- In-house testing captures revenue currently routed to outside reference labs.
- Same-visit result removes the second-visit chair time and front-desk callback labor.
- Single-SKU procurement consolidates a budget line that used to span three or four CPTs.
- Supports clinic-level antibiotic-stewardship reporting by providing analyte-level data during the visit.
Common questions
Urgent Care, in detail.
01 How long does the test take?
Approximately fifteen minutes from specimen to result, returned within the same visit.
02 Does UroSure replace urine culture?
No. UroSure detects six urogenital-infection analytes. Bacterial UTI culture remains a separate workflow when indicated by symptoms or UA findings.
03 What about pregnancy testing or other co-orders?
UroSure runs from a standard urine cup. Other point-of-care urine tests your clinic already runs (β-hCG, dipstick) can use the same collection.
04 Can staff run UroSure without specialized training?
UroSure is not CLIA-waived (moderate complexity). It must be run by qualified clinical staff at a CLIA-certified site — confirm staff scope with your CLIA director before deployment. Virtual training is included with the first wholesale order; an in-service visit is available for qualifying volumes.
05 How is this priced vs a typical send-out?
Wholesale per-kit pricing is set to be competitive with the all-in send-out CPT bundle for the same six analytes. Specific tiers (1, 5, 25, 100+ cases) are scoped to your monthly volume — email sales@urosurewholesale.com for a quote.
Next step
Bring UroSure to your practice.
Order a paid five-pack sample, or request a wholesale pricing quote sized for your practice.